Delayed tPA treatment (beyond 4.5 hr post-stroke) is paralleled with complications including hemorrhagic transformation, free radical production, up-regulation of MMP-9, blood-brain barrier (BBB) leakage, and neurovascular cell death (11, 12). The gene discussed is MMP9; the disease is stroke disorder.